Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

New TB Treatment Guidelines: A Clinician's Guide to the ATS/CDC/ERS/IDSA 2025 Update

Webinar/Podcast
New TB Treatment Guidelines: A Clinician's Guide to the ATS/CDC/ERS/IDSA 2025 Update

his webinar session features a case-based discussion on the management of tuberculosis in alignment with the 2025 ATS/CDC/ERS/IDSA Clinical Practice Guidelines. Lahari Tumuluri, MD (Tulane University), will present two TB cases illustrating the application of these guidelines. Jussi Saukkonen, MD (Boston University), and Charles Daley, MD (National Jewish), will review the guideline development process, supporting evidence, and practical implications for treating drug-sensitive and drug-resistant TB, drawing on real-world clinical experience. The session will be moderated by Eva Otoupalova, MD (Tulane University).

Author:

American Thoracic Society

Audiences:

Health Professionals

Topic:

TB Treatment

Language:

English

View Video

Related Materials

Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

The American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America jointly sponsored this new practice guideline on the treatment of drug-resistant tuberculosis (DR-TB). The document includes recommendations on the treatment of multidrug-resistant TB (MDR-TB) as well as isoniazid-resistant but rifampin-susceptible TB.

Guideline

2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Webinar

The 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis webinar provides an overview of the guidelines development process, key changes in recommendations, and the evidence supporting the changes.

Webinar

Practical Implementation of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines: Caveats and Controversies

This webinar provides an overview of the 2016 ATS/CDC/IDSA Treatment of Drug Susceptible Tuberculosis Guidelines and practical tips for implementation. Case studies are also presented.

Webinar

Global resources for the prevention,
management, and elimination of TB.